Recently, in The New York Times there was an article entitled, F.D.A. Scientists Accuse Agency Officials of Misconduct. Eight F.D.A. scientists wrote a “private” letter to Congress accusing top F.D.A. officials of “engaging in serious misconduct by ignoring concerns of scientists at the FDA and approving for sale unsafe or ineffective medical devices.”
According to the article these medical devices include products like cardiac stents, nerve stimulators to relieve depression, imaging equipment and breast implants.
The New York Times article states, “The letter says that the scientist have documentary evidence that senior agency managers corrupted the scientific review of medical devices by ordering experts to change their opinions and conclusions in violation of the law.”
In working on my film, Absolutely Safe, I filmed from beginning to end the last two F.D.A. regulatory hearings on silicone breast implants. In the 2005 hearing, I witnessed F.D.A. scientists heavily criticize the amount and quality of the scientific data that one of the breast implants manufacturers presented to the panel. Despite the scientists concerns, the scientific panel recommended approval of silicone breast implants.
I watched a breast implant manufacturer acknowledge an important point about the data accumulated in their studies. If a woman had her implants removed she was dropped from their study because she no longer had their product in her chest. If a woman is having problems from her implants and has them removed, it is essential to follow that woman’s health. What are her symptoms? Does her health improve after explantation? Does her health get worse? Valuable data lost because of essentially a loophole where the manufacturer can claim they do not have to include that vital information. No F.D.A. official publicly protested this methodology in the hearing.
I questioned an F.D.A. official on the issue of conflict of interest. In the last hearing there were four plastic surgeons that earned as least part of their livelihood putting in implants. Could they be unbiased in their opinion? Was it a conflict of interest? I posed these questions to an F.D.A. official and she said the F.D.A. needed their expertise on the these panels. There was no acknowledgement of a possible conflict of interest.
There have been serious questions raised on the quality and amount of research done by breast implant manufacturers for years. Silicone implants were FDA approved on two to three years of safety data. It is widely accepted that problems with implants increase over the amount of time a woman has them in her body. So where is the research on women who have had implants for 10 years or 20 years? Implants have been on the market for over 40 years.
The content of this letter should be not be private. Hundreds of thousands of women are getting breast implants every year. If there are serious questions about the approval process of these devices the public needs to be warned immediately. The House Committee on Energy and Commerce will investigate the accusations of this letter. Their investigation should be speedy, thorough and transparent. The health of thousands of women is at stake.
Thursday, May 21, 2009
Tuesday, May 12, 2009
I have sitting in front of me a letter dated October 14, 2008 addressed to Representative John D. Dingell. Representative Dingell is the head of the Committee on Energy and Commerce in the Congress.
The first paragraph of the letter states:
“This letter seeks your urgent intervention because of serious misconduct by managers of the U.S. Drug Administration (FDA) at the Center for Devices and Radiological Health (CDRH) is interfering with our responsibility to ensure the safety and effectiveness of medical devices for the American public and with FDA’s mission to protect and promote the health of all Americans. Mangers at CDRH have failed to follow the laws, rules, regulations and Agency Guidance to ensure the safety and effectiveness of medical devices and consequently, they have corrupted the scientific review of medical devices. This misconduct reaches the highest levels of CDRH management including the Center Director and Director of the Office of Device Evaluation (ODE).”
The letter is redacted (certain sections blacked out) including who sent the letter. It is on the letter head of the Department of Health and Human Resources which is the branch of government responsible for oversight of the FDA.
This is a five page letter that makes clear a shocking point many times over. “There is documentary evidence than managers at Office of Device Evaluation have corrupted and interfered with the scientific review of medical devices.” The documentary evidence has been characterized as “compelling, convincing and sufficient enough to justify curative and disciplinary actions.” According to this letter, the written documentary evidence would seem to include internal emails, reviews, meeting minutes, etc.
There are hundreds of medical devices that are regulated by the FDA. These include silicone and saline breast implants, cardiac stents, imaging equipment and nerve stimulators.
From the dates in this redacted letter, these accusations of corruption were first presented to FDA officials on May 31, 2008. Six months ago. It was determined by an internal FDA official that the evidence was “compelling,” “convincing,” and “sufficient” by the end of August of 2008.
So where is the public warning? What devices have been called into question? What if you or your loved one was getting a cardiac stent tomorrow or choosing to have breast augmentation or breast reconstruction with implants?
I would advocate that it is the FDA’s responsibility to sound an alarm to the public clearly and swiftly if there is any doubt on the validity of the approval process of any device they regulate. Internal investigations are called for and needed but where the public warning.
In November of 2007 there was a report issued by the FDA Science Board entitled “FDA Science and Mission at Risk.” The report states, “The industries that the FDA regulates are among the most successful and innovative in our society, and are among the few that contribute to appositive balance of trade with other countries. The importance of the FDA in the nation’s security is similarly profound…THUS THE NATION IS AT RISK IF FDA SCIENCE IS AT RISK.”
So how many people are there walking around today with one of these medical devices in question? Do they not have a right to know?
Write your elected representative and demand Congressional hearings.
Sunday, May 3, 2009
This year, the economy has been front and center on everyone’s mind. Bailouts, banks not lending, high unemployment, people cutting back, the mortgage crisis, etc., etc.
Natasha Singer wrote an article recently in the New York Times, Putting Vanity on Hold. Her article discusses the ramifications the downturn of the economy will have on cosmetic surgery. Will it slow down? Will people still make it a priority? The by–line of the article is:
Americans have been plastic surgery-obsessed. In a recession, will ideals of beauty loosen up?
I read one thing towards the end of the article that made me think at least one huge American company thinks not. In December 2008, Johnson & Johnson announced it will buy Mentor Corporation, one of the leading manufacturers of breast implants for about 1.1 BILLION dollars. Yes, that is 1.1 billion dollars in an economic downturn that some suggest is reminiscent of the Great Depression. Yet, Johnson and Johnson will buy Mentor Corporation for this huge sum of money. Johnson & Johnson must have predicted that Mentor’s profitable breast implants business is recession proof. Women will still be spending their hard earned dollars on breast implants.
When I think of the company Johnson & Johnson, I think of babies – baby lotion, baby bottles, and baby shampoo. Brings to mind the virtues of purity and caring. I went to their website and read their company credo –
“The values that guide our decision making are spelled out in our Credo. Put simply, our credo challenges us to put the needs and the well-being of the people we serve first.”
In this case, Johnson & Johnson has a great deal of work to do when they acquire Mentor Corporation. Given their credo they will have to devise a way that is accessible and transparent to provide Informed Consent to the women that will choose their new product –breast implants.
In my documentary film, Absolutely Safe, I raised several questions about breast implant safety. The quality and quantity of the safety studies on implants, the possible risks and complications and how much women understand what those are, why women choose this product and the question of long-term safety of breast implants, to name a few. One of the characters in the film, Wendi, chose to have her silicone implants removed after 20 years. Her implants had disintegrated into a sticky mess.
I continue to hear stories of implants gone bad, re-operations for ruptured implants, infection, hardening of the implants, and removal of the implant due to pain. There are serious and very real complications and risks with breast implants. And there are serious and very real unknowns about the long-term safety of implants.
Women deserve to be informed. They deserve Informed Consent. The Johnson and Johnson credo is needed here – “Our credo challenges us to put the needs and the well-being of the people we serve first.” Women and their health need to be put first. Let’s pray that Johnson and Johnson takes on that challenge. It is essential and so needed in the discussion of breast implant safety.